NasdaqCM - Delayed Quote USD

Ainos, Inc. (AIMD)

1.0400 -0.0200 (-1.89%)
At close: May 14 at 4:00 PM EDT
1.0400 0.00 (0.00%)
Pre-Market: 4:46 AM EDT
Loading Chart for AIMD
DELL
  • Previous Close 1.0600
  • Open 1.0500
  • Bid --
  • Ask --
  • Day's Range 1.0301 - 1.0899
  • 52 Week Range 0.7900 - 6.1000
  • Volume 37,357
  • Avg. Volume 1,419,881
  • Market Cap (intraday) 6.513M
  • Beta (5Y Monthly) 1.48
  • PE Ratio (TTM) --
  • EPS (TTM) -3.3600
  • Earnings Date Aug 9, 2024 - Aug 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

www.ainos.com

46

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AIMD

Performance Overview: AIMD

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AIMD
49.27%
S&P 500
10.00%

1-Year Return

AIMD
71.11%
S&P 500
27.22%

3-Year Return

AIMD
97.87%
S&P 500
27.58%

5-Year Return

AIMD
--
S&P 500
37.18%

Compare To: AIMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AIMD

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    6.51M

  • Enterprise Value

    10.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    35.57

  • Price/Book (mrq)

    0.27

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.42%

  • Return on Equity (ttm)

    -46.62%

  • Revenue (ttm)

    122.11k

  • Net Income Avi to Common (ttm)

    -13.77M

  • Diluted EPS (ttm)

    -3.3600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.89M

  • Total Debt/Equity (mrq)

    23.29%

  • Levered Free Cash Flow (ttm)

    948.64k

Research Analysis: AIMD

Company Insights: AIMD

Research Reports: AIMD

People Also Watch